Pramipexole dihydrochloride and Serevent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pramipexole dihydrochloride and Serevent. Common interactions include auricular swelling among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people who take Pramipexole dihydrochloride and Serevent have. It is created by eHealthMe based on reports of 8 people who take Pramipexole dihydrochloride and Serevent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

8 people who take Pramipexole dihydrochloride and Serevent together, and have interactions are studied.


What is Pramipexole dihydrochloride?

Pramipexole dihydrochloride has active ingredients of pramipexole dihydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 4,265 Pramipexole dihydrochloride users for its effectiveness, alternative drugs and more.

What is Serevent?

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,097 Serevent users for its effectiveness, alternative drugs and more.

Number of Pramipexole dihydrochloride and Serevent reports submitted per year:

Pramipexole dihydrochloride and Serevent drug interactions.

Common Pramipexole Dihydrochloride and Serevent drug interactions by gender *:

female:

  1. Auricular swelling
  2. Drug ineffective
  3. Hypersensitivity
  4. Inflammation
  5. Purulent discharge
  6. Skin reaction
  7. Blister
  8. Nystagmus
  9. Vertigo
  10. Vomiting

male:

  1. Cardiac failure congestive
  2. Cough
  3. Disease progression
  4. Dyspnoea
  5. Oedema peripheral
  6. Pneumonia
  7. Pulmonary oedema
  8. Constipation
  9. Pyrexia

Common Pramipexole Dihydrochloride and Serevent drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Application site vesicles
  2. Auricular swelling
  3. Disease progression
  4. Dyspnoea
  5. Nystagmus
  6. Oedema peripheral
  7. Pneumonia
  8. Pulmonary oedema
  9. Vertigo
  10. Vomiting

* Approximation only. Some reports may have incomplete information.

Do you take Pramipexole dihydrochloride and Serevent?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Pramipexole dihydrochloride and Serevent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pramipexole dihydrochloride interactions:

Browse all interactions between Pramipexole dihydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Serevent interactions:

Browse all interactions between Serevent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pramipexole dihydrochloride and salmeterol xinafoate (the active ingredients of Pramipexole dihydrochloride and Serevent, respectively), and Pramipexole dihydrochloride and Serevent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: